South & Central America Custom Antibody Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The South & Central America custom antibody services market size is expected to reach US$ 49.87 million by 2031 from US$ 23.73 million in 2023. The market is estimated to record a CAGR of 9.7% from 2023 to 2031.

Executive Summary and South & Central America Custom Antibody Services Market Analysis:

The custom antibody services market in South & Central America is gradually expanding, driven by growing investment in biomedical research, increasing prevalence of chronic diseases, and a rising demand for targeted therapeutics. Countries like Brazil and Argentina are emerging as key contributors due to improvements in research infrastructure and healthcare spending. Academic institutions and biotechnology firms in the region are increasingly outsourcing antibody development to specialized service providers to accelerate drug discovery and diagnostics. Although the market faces challenges such as limited funding and regulatory hurdles, technological advancements and international collaborations are expected to support steady growth in the coming year.

South & Central America Custom Antibody Services Market Strategic Insights

Get more information on this report Request Free Sample PDF

South & Central America Custom Antibody Services Market Segmentation Analysis

Key segments that contributed to the derivation of the South & Central America custom antibody services market analysis are product type, service type, application, disease indication, source, and end user.

• Based on product type, the South & Central America custom antibody services market is segmented into monoclonal, polyclonal hybridoma, recombinant antibody, and others. The monoclonal held the largest share of the market in 2023.
• Based on service type, the South & Central America custom antibody services market is segmented into antibody discovery and development, antibody production services, and others. The antibody discovery and development held the largest share of the market in 2023.
• Based on application, the South & Central America custom antibody services market is segmented into immunohistochemistry, western blot & IP, ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. The ELISA held the largest share of the market in 2023.
• Based on disease indication, the South & Central America custom antibody services market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others. The oncology held the largest share of the market in 2023.
• Based on source, the South & Central America custom antibody services market is segmented into chicken, rabbits, rats, guinea pigs, mouse or humanized mice, and others. The mouse or humanized mice held the largest share of the market in 2023.The mouse or humanized mice segment is further sub segmented into monoclonal antibody platform, BsAB discovery platform, bispecific ADC platform, TCR-mimic antibody platform, Anti-GPCR antibody technology platform, and others.
• Based on end user, the South & Central America custom antibody services market is segmented into life science industry, pharmaceutical & biotech companies, academic & research institutes, and contract research organizations. The life science industry held the largest share of the market in 2023.

South & Central America Custom Antibody Services Market Outlook

Recombinant antibody engineering has a wide scope of potential for drug developers and researchers to create specific molecules with specific attributes ideally suited for treating specific diseases. Several drug developers are already using AI technologies in the prediction and analysis of potential therapeutics from antibody sequences, using algorithms to assess their potential before production has commenced. For instance, Foundation Medicine develops, manufactures, and sells genomic profiling assays on the basis of next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas that can be utilized to match patients with targeted therapies, immunotherapies, and clinical trial options. Such companies also partner with the biopharma industry to help discover, develop, and distribute the next breakthrough treatments for patients. The Medicines Discovery Catapult is testing (on a computer) an in-silico pipeline for identifying new molecules for cancer treatment; for example, applying AI to find new disease drivers as well as candidate drugs for lung cancer. Thus, technological advancements using recombinant antibodies are expected to bring new trends into the custom antibody services market in the coming years.

South & Central America Custom Antibody Services Market Country Insights

Based on country, the South & Central America custom antibody services market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.

The prevalence of chronic diseases has been linked to the aging population in Brazil. According to the Pan American Health Organization in 2022, the country has more than 30 million older adults aged 60 years and above, representing 13% of its population. By 2030, the number of people from this age group will reach nearly 50 million, accounting for 24% of the total population. The World Health Organization (WHO) and the Brazilian Institute of Geography and Statistics reported that the geriatric population in Brazil (aged ≥ 60 years) is expected to reach ~55 million by 2040. Geriatric populations often experience a higher incidence of chronic diseases such as autoimmune disorders, cancer, and infectious diseases. Custom antibodies can be developed to target specific biomarkers associated with these conditions, facilitating more effective diagnosis and treatment.

In October 2020, the Brazilian Health Regulatory Agency authorized Sorrento Therapeutics, a clinical-stage, antibody-centric biopharmaceutical company, to conduct a large-scale Phase 2 Clinical Trial for monoclonal antibodies in mild, moderate, and severe COVID-19 Patients. Further, in December 2020, GenScript received approval from ANVISA to use the cPass SARS-CoV-2 Neutralization Antibody Detection Kit to detect neutralizing antibodies. In April 2021, Bio-Manguinhos/Fiocruz (Health Ministry of Brazil) and PlantPraxis Biotecnologia collaborated to develop a biosimilar pembrolizumab in the Brazilian market. Such government initiatives are expected to encourage more research in the Brazilian biotechnology and biopharmaceutical industries, eventually stimulating the economy and gathering industry interest. Ongoing healthcare infrastructure developments and increasing modern diagnostic laboratories are also projected to fuel the market in the coming years. The Collegiate Board Resolution guides good practice in using antibodies for research and clinical use in Brazil.

South & Central America Custom Antibody Services Market Report Highlights

South & Central America Custom Antibody Services Market Company Profiles

Some of the key players operating in the market include Thermo Fisher Scientific Inc; Sino Biological Inc.; GenScript Biotech Corporation; Biochain Incorporated; R&D Systems, Inc; Kaneka Eurogentec S.A.; Fortis Life Sciences; Precision Antibody (A&G Pharmaceutical, Inc.; Biocytogen Pharmaceuticals Beijing Co Ltd; Abgenex; Creative Biolabs Inc; Agilent Technologies Inc; Bioklone; and Scantibodies Laboratory, Inc. among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Custom Antibody Services Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South & Central America Custom Antibody Services Market Country and Regional Insights